Fresenius Medical Care AG · FME.DE
As of the latest run, Fresenius Medical Care AG (FME.DE) scores 52/100 overall — a decent but mixed profile. Its strongest dimension: profitability (88/100); the one that most warrants attention: valuation (31/100).
Pillar marked “not applicable” for this profile: growth — typical of financials, whose balance sheet follows its own logic; the overall score is built on the remaining pillars.
Three pillars judge the company (profitability, growth, financial health), three judge the stock (valuation, momentum, risk). The score is recomputed every day from Yahoo Finance market data — the one shown above reflects today's state.
Profitability comes in at 88/100 — above-average margins and return on capital. Momentum comes in at 68/100 — a well-oriented price trend.
The breakdown of each pillar — and a plain-English explanation of what it measures — is available in the full analysis, free and updated every day.
Valuation falls to 31/100 — a stretched price relative to the stock's own valuation history. The risk pillar falls to 33/100 — high volatility — the stock swings hard, both ways. Financial health falls to 38/100 — a balance sheet under strain, on debt or liquidity.
No score replaces your own judgment: Stock Analyzer is a tool for analysis and understanding, not investment advice.